Study of real world efficacy and drug resistance associated substitutions of Sofosbuvir and Velpatasvir treatment for patients with HCV infectio
Not Applicable
Recruiting
- Conditions
- Hepatitis C
- Registration Number
- JPRN-UMIN000035511
- Lead Sponsor
- Kyoto Prefectural University of Medicine, Department of Molecular Gastroenterology and Hepatology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with coinfection with hepatitis B virus or human immunodeficiency virus, autoimmune hepatitis, primary biliary cirrhosis, hemochromatosis or Wilson's disease were excluded. Patients with uncontrollable hypertension or diabetes mellitus and those with a history of alcohol abuse were also excluded.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method